Eptifibatide 70436-0026-80
- Manufacturer
- Slate Run Pharmaceuticals, Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 22, 2019
- Listing Expires
- December 31, 2027
- Application
- ANDA209864
Need to source Eptifibatide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Eptifibatide | 2 mg/mL |
Drug Class
Platelet Aggregation Inhibitor [EPC]Decreased Platelet Aggregation [PE]Platelet Aggregation Inhibitor [EPC]
Selected Package
70436-0026-80Selected10 mL in 1 VIAL (70436-026-80)